Medicenna Therapeutics Corp. announced the departure of Jeff Caravella as Chief Business Officer, effective October 26, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 CAD | -4.22% | -7.72% | +440.48% |
13/05 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
13/05 | Medicenna Brief: Providing Update on its Presentations at the 2024 ASCO Annual Meeting | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+440.48% | 12Cr | |
+41.79% | 5.09TCr | |
-0.56% | 4.21TCr | |
+49.62% | 4.2TCr | |
-7.20% | 2.92TCr | |
+12.59% | 2.6TCr | |
-21.51% | 1.89TCr | |
+6.92% | 1.32TCr | |
+24.91% | 1.22TCr | |
+29.60% | 1.22TCr |
- Stock Market
- Equities
- MDNA Stock
- News Medicenna Therapeutics Corp.
- Medicenna Therapeutics Corp. Announces the Departure of Jeff Caravella as Chief Business Officer